Karinna Saxby

Loop profile Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Cross Sectional

Affordable Care Act

Cardiovascular Risk Factors

Top Venues

Health economics

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco

American journal of public health

Expert review of pharmacoeconomics & outcomes research

This page only lists publications with an associated author ORCID identifier.

Publications

Karinna Saxby, Yuting Zhang, Zoe Aitken
Structural Stigma and Disparities in Long-Term Health Conditions Among Australians in Same-Sex Relationships: 2021 Australian Census. American journal of public health (2024)
Karinna Saxby, Joshua M Byrnes, Sonja C de New, Son Nghiem, Dennis Petrie
Does affirmative action reduce disparities in healthcare use by Indigenous peoples? Evidence from Australia's Indigenous Practice Incentives Program. Health economics 32 (4) (2023)
Karinna Saxby, Joshua M Byrnes, Sonja C de New, Son Nghiem, Dennis Petrie
Does affirmative action reduce disparities in healthcare use by Indigenous peoples? Evidence from Australia's Indigenous Practice Incentives Program. Health economics (2023)
Karinna Saxby, Joshua M Byrnes, Sonja C de New, Son Nghiem, Dennis Petrie
Does affirmative action reduce disparities in healthcare use by Indigenous peoples? Evidence from Australia's Indigenous Practice Incentives Program. Health economics 32 (4) (2023)
Karinna Saxby, Andrew Ireland, Peter Ghijben, Rohan Sweeney, Kah-Ling Sia, Esa Y H Chen, Michael Farrell, Hayden J McRobbie, Ryan Courtney, Dennis Petrie
Household composition and smoking behaviour in a prospective longitudinal Australian cohort. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco (2022)
Karinna Saxby, Carolyn Nickson, Gregory B Mann, Allan Park, Hannah L Bromley, Louiza S Velentzis, Pietro Procopio, Karen Canfell, Dennis Petrie
Moving beyond the stage: how characteristics at diagnosis dictate treatment and treatment-related quality of life year losses for women with early stage invasive breast cancer. Expert review of pharmacoeconomics & outcomes research 21 (4) (2021)